Shahid Rafiq, MD
Anesthesiology · Stamford, CTNPI 1487781308
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,592 of the $1,841 with a category attached, or 86.5%. 16 manufacturers reported payments, led by Novartis at 40.1% of the total. Reporting peaked in 2023 at $998 and has fallen 88.3% since, to $116 in 2025. Among anesthesiology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $31.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$739
- Takeda Pharmaceuticals U.S.A., Inc.$288
- Johnson & Johnson$211
- Bristol Myers Squibb$111
- Merck$92
- Genentech USA, Inc.$74
- plus $326 from 10 others
Across 1 payment — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$5K
What the payments were for
- Travel & lodging$24914%
- Food & beverage$1,59286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 5 | $739 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $288 |
| Johnson & Johnson | 9 | $211 |
| Bristol Myers Squibb | 6 | $111 |
| Merck | 4 | $92 |
| Genentech USA, Inc. | 1 | $74 |
| Neurocrine Biosciences, Inc. | 5 | $74 |
| EMD Serono, Inc. | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Redhill Biopharma Inc. | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| AbbVie | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAYZENT$125
How this compares
$1,841 in reported general payments places this provider in the 90th percentile of 664 anesthesiology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Stamford
- Jay FreilichStamford$2K
- Kamel GhandourStamford$1K
- Zeev KainNew Haven$273K
- Alison ConsidineNew Haven$82K
- Sanjay SinhaHartford$42K
- William RosenblattNew Haven$40K
- Paul HeerdtNew Haven$36K
- Antonio PazBrookfield$27K
- Honghui FengOld Saybrook$20K
- Prakash PatelNew Haven$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.